This variability may likely be attributable to differences in patient susceptibility and clinician sensitivity in attributing clinical relevance to arrhythmias detected by ILRs—such as extrasystoles or short-duration supraventricular tachycardias (SVTs). This evidence concerns the gene IARS1 and cardiac arrhythmia.